期刊文献+

餐后高血糖与心血管病 被引量:39

原文传递
导出
摘要 餐后高血糖(postprandial hyperglycemia)指正常餐或标准试餐后食物在消化吸收过程中的血糖升高值超过正常范围。餐后血糖水平受到餐后B.细胞功能(主要是早相分泌功能),靶组织、器官(主要是肌肉、脂肪组织及肝脏)对胰岛素的敏感性、胃肠道消化、吸收等功能,以及进食量及成分、食物烹调方法、摄食速度等多种因素的影响。负荷后高血糖(postchallenge hyperglycemia,posdoad hyperglycemia)指口服75g葡萄糖耐量试验(OGTT)中2h血糖水平≥7.8mmol/L(≥140mg/dl)(糖耐量受损),或≥11.1mmol/L(≥200ms/dl)(糖尿病)。有研究表明OGIT2h血糖水平与摄入标准混合餐(含脂肪10.7g,蛋白质12.1g,简单糖8.9g,淀粉41.1g,食用纤维3.8g,共提供345热卡)后的血糖水平甚为相近,提示OGTT在一定程度上可反映进餐后糖代谢的变化状况。
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2006年第3期i0001-i0006,共6页 Chinese Journal of Endocrinology and Metabolism
  • 相关文献

参考文献21

  • 1Wolever TMS, Chiassen JL, Csima A, et al. Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g glucose. Diabetes Care,1998,21:336-340. 被引量:1
  • 2Coutinho M, Gerstein HC, Wang Y, et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care, 1999,22:233-240. 被引量:1
  • 3DECODE Study Group, the European Diabetes Epidemiology Group.Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med, 2001 ; 12 ; 161 : 397-405. 被引量:1
  • 4Nakagami T; DECODA Study Group. Hypergiycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia, 2004,47:385-394. 被引量:1
  • 5Sorkin JD, Muller DC, Fleg JL, et al.The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality, Data from the Baltimore longitudinal study of aging with a critical review of the literature. Diabetes Care, 2005,28:2626-2632. 被引量:1
  • 6Hanefeld M, Koehler C, Henkel E, et al. Post-challenge hyperlycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for atherosclerosis and Diabetes. Diabet Med, 2000,17: 835-840. 被引量:1
  • 7Hanefeld M, Chiasson JL, Koehler C, et al. Acarbose slows pregression of intima-media thickness of the carotid artiefies in subjects with impaired glucose tolerance. Stroke, 2004,35:1073-1078. 被引量:1
  • 8Yamasaki Y, Katakami N, Hayaishi-Okano R, et al. Alpha-glucosidase inhibitor reduces the progression of carotid intima-media thickness. Diabetes Res Clin Pract, 2005,67:204-210. 被引量:1
  • 9Esposito K, Giugliano D, Nappo F, et al. Campanian Postprandial Hyperglycemia Study Group. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.Circulation, 2004,110:214-219. 被引量:1
  • 10Chiasson JL, Josse RG, Gomis R, et al. STOP-NIDDM trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA, 2003,290:486-494. 被引量:1

二级参考文献15

  • 1Meigs JB, Nathan DM, D′Agostino RB Sr, et al. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham offspring study. Diabetes Care, 2002,25:1845-1850. 被引量:1
  • 2Edelstein SL, Knowler WC, Bain RF, et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective study. Diabetes, 1997,46:701-710. 被引量:1
  • 3Unwin N, Shaw J, Zimmet P, et al. Impaired glucose tolerance and impaired fasting glycaemias: the current status on definition and intervention. Diabet Med, 2002,19:708-723. 被引量:1
  • 4Lindahl B, Dinesen B, Eliasson M, et al.High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population. J Metab, 1999,48:1197-1202. 被引量:1
  • 5Wannamethec SG, Perry IJ, Shaper AG. Nonfasting serum glucose and insulin concentration and the risk of stroke. Stroke,1999,30:1780-1786. 被引量:1
  • 6Temelkova-Kurktschiev T, Henkel E, Schaper F, et al. Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia and underestimated evil? Exp Clin Endocrinol Diabetes, 2000,108:93-99. 被引量:1
  • 7Pickup JC, Crook MA. Is type Ⅱ diabetes mellitus a disease of the innate immune system? Diabetologia, 1998,41:1241-1248. 被引量:1
  • 8Pickup JC, Mattock MB, Chuseney GD, et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia, 1997,40:1286-1292. 被引量:1
  • 9McMillan DE. Increased levels of acute-phase serum proteins in diabetes. Metabolism, 1989,38:1042-1046. 被引量:1
  • 10Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 2001,286:327-334. 被引量:1

共引文献53

同被引文献211

引证文献39

二级引证文献213

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部